Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Long-term survival results after treatment for oligometastatic brain disease.

Nieder C, Hintz M, Popp I, Bilger A, Grosu AL.

Rep Pract Oncol Radiother. 2020 May-Jun;25(3):307-311. doi: 10.1016/j.rpor.2020.03.001. Epub 2020 Mar 4.

PMID:
32194350
2.

Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.

Popp I, Rau S, Hintz M, Schneider J, Bilger A, Fennell JT, Heiland DH, Rothe T, Egger K, Nieder C, Urbach H, Grosu AL.

Cancer. 2020 Mar 6. doi: 10.1002/cncr.32787. [Epub ahead of print]

PMID:
32142171
3.

Validation of the graded prognostic assessment for gastrointestinal cancers with brain metastases (GI-GPA).

Nieder C, Hintz M, Popp I, Bilger A, Grosu AL.

Radiat Oncol. 2020 Feb 13;15(1):35. doi: 10.1186/s13014-020-1484-9.

4.

The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.

Torres AD, Spurgeon ME, Bilger A, Blaine-Sauer S, Uberoi A, Buehler D, McGregor SM, Ward-Shaw E, Lambert PF.

Virology. 2020 Feb;541:1-12. doi: 10.1016/j.virol.2019.12.002. Epub 2019 Dec 5.

PMID:
31826841
5.

Divergent clonal evolution of a common precursor to mantle cell lymphoma and classic Hodgkin lymphoma.

Tashkandi H, Petrova-Drus K, Batlevi CL, Arcila ME, Roshal M, Sen F, Yao J, Baik J, Bilger A, Singh J, de Frank S, Kumar A, Aryeequaye R, Zhang Y, Dogan A, Xiao W.

Cold Spring Harb Mol Case Stud. 2019 Dec 13;5(6). pii: a004259. doi: 10.1101/mcs.a004259. Print 2019 Dec.

6.

Perspectives and Practice in the Identification and Treatment of Opioid Use, Alcohol Use, and Depressive Disorders.

Wolk CB, Doubeni CA, Klusaritz HA, Bilger A, Paterson E, Oslin DW.

Psychiatr Serv. 2019 Oct 1;70(10):940-943. doi: 10.1176/appi.ps.201800378. Epub 2019 Jun 12.

PMID:
31185852
7.

Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes.

Shin MK, Payne S, Bilger A, Matkowskyj KA, Carchman E, Meyer DS, Bentires-Alj M, Deming DA, Lambert PF.

Clin Cancer Res. 2019 Mar 15;25(6):1889-1900. doi: 10.1158/1078-0432.CCR-18-2843. Epub 2018 Dec 7.

8.

Conceptualizing restorative justice for people with mental illnesses leaving prison or jail.

Thomas EC, Bilger A, Wilson AB, Draine J.

Am J Orthopsychiatry. 2019;89(6):693-703. doi: 10.1037/ort0000316. Epub 2018 Nov 8.

PMID:
30411905
9.

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.

Bilger A, Bretzinger E, Fennell J, Nieder C, Lorenz H, Oehlke O, Grosu AL, Specht HM, Combs SE.

Cancer Med. 2018 Jun;7(6):2350-2359. doi: 10.1002/cam4.1486. Epub 2018 May 9.

10.

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases.

Combs SE, Bilger A, Diehl C, Bretzinger E, Lorenz H, Oehlke O, Specht HM, Kirstein A, Grosu AL.

Cancer Med. 2018 Jun;7(6):2319-2327. doi: 10.1002/cam4.1477. Epub 2018 Apr 25.

11.

Local control and overall survival after frameless radiosurgery: A single center experience.

Bilger A, Frenzel F, Oehlke O, Wiehle R, Milanovic D, Prokic V, Nieder C, Grosu AL.

Clin Transl Radiat Oncol. 2017 Nov 6;7:55-61. doi: 10.1016/j.ctro.2017.09.007. eCollection 2017 Dec.

12.

Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).

Nieder C, Hintz M, Bilger A, Oehlke O, Grosu AL.

J Clin Med Res. 2018 Mar;10(3):178-181. doi: 10.14740/jocmr3248w. Epub 2018 Jan 26.

13.

Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA).

Nieder C, Hintz M, Oehlke O, Bilger A, Grosu AL.

Radiat Oncol. 2017 Jun 26;12(1):107. doi: 10.1186/s13014-017-0844-6.

14.

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.

Bilger A, Plowshay J, Ma S, Nawandar D, Barlow EA, Romero-Masters JC, Bristol JA, Li Z, Tsai MH, Delecluse HJ, Kenney SC.

Oncotarget. 2017 Jul 4;8(27):44266-44280. doi: 10.18632/oncotarget.17863.

15.

The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases.

Nieder C, Hintz M, Oehlke O, Bilger A, Grosu AL.

Clin Transl Oncol. 2017 Sep;19(9):1141-1146. doi: 10.1007/s12094-017-1651-0. Epub 2017 Mar 29.

PMID:
28357633
16.

Exploring Personal Medicine as Part of Self-Directed Care: Expanding Perspectives on Medical Necessity.

Snethen G, Bilger A, Maula EC, Salzer MS.

Psychiatr Serv. 2016 Aug 1;67(8):883-9. doi: 10.1176/appi.ps.201500311. Epub 2016 Apr 1.

PMID:
27032663
17.

Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases.

Bilger A, Milanovic D, Lorenz H, Oehlke O, Urbach H, Schmucker M, Weyerbrock A, Nieder C, Grosu AL.

Clin Neurol Neurosurg. 2016 Mar;142:81-86. doi: 10.1016/j.clineuro.2016.01.008. Epub 2016 Jan 14.

PMID:
26816106
18.

Takotsubo syndrome triggered by acute intermittent porphyria attack: An unusual stressor for catecholamine-induced cardiomyopathy.

Messas N, Willemain R, Bilger A, Rondeau-Lutz M, Kuhnert C, Mertes PM, Morel O, Collange O.

Int J Cardiol. 2016 Mar 15;207:28-30. doi: 10.1016/j.ijcard.2016.01.035. Epub 2016 Jan 6. No abstract available.

PMID:
26788817
19.

Anticipation of brain shift in Deep Brain Stimulation automatic planning.

Hamzé N, Bilger A, Duriez C, Cotin S, Essert C.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:3635-8. doi: 10.1109/EMBC.2015.7319180.

PMID:
26737080
20.

Extensive pulmonary embolism after severe postpartum haemorrhage: management with an inferior vena cava filter.

Bilger A, Pottecher J, Greget M, Boudier E, Diemunsch P.

Int J Obstet Anesth. 2014 Nov;23(4):390-3. doi: 10.1016/j.ijoa.2014.06.002. Epub 2014 Jun 19.

PMID:
25223642
21.

FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.

Bilger A, Bittner MI, Grosu AL, Wiedenmann N, Meyer PT, Firat E, Niedermann G, Weber WA, Milanović D.

Strahlenther Onkol. 2014 Oct;190(10):957-61. doi: 10.1007/s00066-014-0693-2. Epub 2014 Jun 14.

PMID:
24928248
22.

Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis.

Oberley CC, Bilger A, Drinkwater NR.

Mol Carcinog. 2015 Oct;54(10):959-70. doi: 10.1002/mc.22165. Epub 2014 May 17.

23.

Computation and visualization of risk assessment in deep brain stimulation planning.

Bilger A, Duriez C, Cotin S.

Stud Health Technol Inform. 2014;196:29-35.

PMID:
24732475
24.

Biomechanical simulation of electrode migration for deep brain stimulation.

Bilger A, Dequidt J, Duriez C, Cotin S.

Med Image Comput Comput Assist Interv. 2011;14(Pt 1):339-46.

PMID:
22003635
25.

Identification of susceptibility loci in a mouse model of KRASG12D-driven pancreatic cancer.

Jorgenson TC, Williams BR, Wendland A, Bilger A, Sandgren EP, Drinkwater NR.

Cancer Res. 2010 Nov 1;70(21):8398-406. doi: 10.1158/0008-5472.CAN-09-3980. Epub 2010 Oct 19.

26.

Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.

Peychal SE, Bilger A, Pitot HC, Drinkwater NR.

Carcinogenesis. 2009 May;30(5):879-85. doi: 10.1093/carcin/bgp054. Epub 2009 Mar 2.

27.

Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma.

Attia S, Holen KD, Thomas JP, Richie K, Dzelak T, Teeter K, Warren D, Bilger A, Fine J, Eickhoff J, Drinkwater N, Mulkerin D, Morgan-Meadows S.

Clin Adv Hematol Oncol. 2008 Jan;6(1):44-54.

PMID:
18322441
28.

Widespread hyperplasia induced by transgenic TGFalpha in ApcMin mice is associated with only regional effects on tumorigenesis.

Bilger A, Sullivan R, Prunuske AJ, Clipson L, Drinkwater NR, Dove WF.

Carcinogenesis. 2008 Sep;29(9):1825-30. doi: 10.1093/carcin/bgn038. Epub 2008 Feb 28.

29.

A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines.

Bilger A, Bennett LM, Carabeo RA, Chiaverotti TA, Dvorak C, Liss KM, Schadewald SA, Pitot HC, Drinkwater NR.

Genetics. 2004 Jun;167(2):859-66.

30.

The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.

Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH, Gould KA, Borenstein N, Lander ES, Dove WF.

Oncogene. 2000 Jun 29;19(28):3182-92.

31.
32.

Manipulation of the mouse germline in the study of Min-induced neoplasia.

Bilger A, Shoemaker AR, Gould KA, Dove WF.

Semin Cancer Biol. 1996 Oct;7(5):249-60. Review.

PMID:
9110402
33.
34.

Nuclear polyadenylation factors recognize cytoplasmic polyadenylation elements.

Bilger A, Fox CA, Wahle E, Wickens M.

Genes Dev. 1994 May 1;8(9):1106-16.

35.

Regional cerebral blood flow response to acute hypoxia changes with postnatal age in the rat.

Bilger A, Nehlig A.

Brain Res Dev Brain Res. 1993 Dec 17;76(2):197-205.

PMID:
8149586
37.

Acute hypoxia induces specific changes in local cerebral glucose utilization at different postnatal ages in the rat.

Bômont L, Bilger A, Boyet S, Vert P, Nehlig A.

Brain Res Dev Brain Res. 1992 Mar 20;66(1):33-45.

PMID:
1600631

Supplemental Content

Loading ...
Support Center